Education
About Us
Working with TipRanks
Follow Us
Kontafarma China Holdings Ltd (HK:1312)
:1312
RESEARCH TOOLSreports
Total Valuation
Kontafarma China Holdings Ltd has a market cap or net worth of HK$172.94M. The enterprise value is HK$383.97M.
Market CapHK$172.94M
Enterprise ValueHK$383.97M
Share Statistics
Kontafarma China Holdings Ltd has 5,588,572,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,588,572,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Kontafarma China Holdings Ltd’s return on equity (ROE) is -0.08 and return on invested capital (ROIC) is -3.32%.
Return on Equity (ROE)-0.08
Return on Assets (ROA)-0.05
Return on Invested Capital (ROIC)-3.32%
Return on Capital Employed (ROCE)-0.04
Revenue Per Employee1.26M
Profits Per Employee-137.23K
Employee Count714
Asset Turnover0.57
Inventory Turnover4.44
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio―
PS Ratio0.00
PB Ratio0.17
Price to Fair Value0.15
Price to FCF4.69
Price to Operating Cash Flow3.72
PEG Ratio0.11
Income Statement
In the last 12 months, Kontafarma China Holdings Ltd had revenue of 897.52M and earned -75.54M in profits. Earnings per share was -0.01.
Revenue897.52M
Gross Profit516.16M
Operating Income-42.51M
Pretax Income-97.98M
Net Income-75.54M
EBITDA-49.93M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was 45.05M and capital expenditures -9.34M, giving a free cash flow of 35.71M billion.
Operating Cash Flow45.05M
Free Cash Flow35.71M
Free Cash Flow per Share<0.01
Dividends & Yields
Kontafarma China Holdings Ltd pays an annual dividend of HK$0.004, resulting in a dividend yield of ―
Dividend Per ShareHK$0.004
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.20
52-Week Price Change0.00%
50-Day Moving Average0.03
200-Day Moving Average0.03
Relative Strength Index (RSI)52.32
Average Volume (3m)826.40K
Important Dates
Kontafarma China Holdings Ltd upcoming earnings date is Sep 1, 2025, TBA (Confirmed).
Last Earnings DateMar 28, 2025
Next Earnings DateSep 1, 2025
Ex-Dividend DateMay 27, 2013
Financial Position
Kontafarma China Holdings Ltd as a current ratio of 1.26, with Debt / Equity ratio of 30.37%
Current Ratio1.26
Quick Ratio1.06
Debt to Market Cap0.61
Net Debt to EBITDA-4.34
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Kontafarma China Holdings Ltd has paid 1.04M in taxes.
Income Tax1.04M
Effective Tax Rate-0.01
Enterprise Valuation
Kontafarma China Holdings Ltd EV to EBITDA ratio is -7.24, with an EV/FCF ratio of 0.00.
EV to Sales0.40
EV to EBITDA-7.24
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
Kontafarma China Holdings Ltd has HK$90.58M in cash and marketable securities with HK$297.19M in debt, giving a net cash position of HK$206.60M billion.
Cash & Marketable SecuritiesHK$90.58M
Total DebtHK$297.19M
Net CashHK$206.60M
Net Cash Per ShareHK$0.04
Tangible Book Value Per ShareHK$0.09
Margins
Gross margin is 57.15%, with operating margin of -4.74%, and net profit margin of -8.42%.
Gross Margin57.15%
Operating Margin-4.74%
Pretax Margin-10.92%
Net Profit Margin-8.42%
EBITDA Margin-5.56%
EBIT Margin-10.30%
Analyst Forecast
The average price target for Kontafarma China Holdings Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast10.93%
EPS Growth Forecast-159.62%